Seattle, WA, United States of America

Keith B Elkon

USPTO Granted Patents = 11 

Average Co-Inventor Count = 3.8

ph-index = 7

Forward Citations = 99(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Keith B. Elkon

Introduction

Keith B. Elkon is a prominent inventor based in Seattle, Washington, whose work has significantly impacted the field of biotechnology. He holds an impressive portfolio of 11 patents, showcasing his creativity and dedication to advancing therapeutic methods.

Latest Patents

Among his notable inventions are two recent patents focused on therapeutic nuclease compositions and methods. These include hybrid nuclease molecules designed for treating immune-related diseases or disorders in mammals. Additionally, he has developed a pharmaceutical composition aimed at addressing such conditions in mammals, reflecting his commitment to improving health outcomes.

Career Highlights

Elkon has had a distinguished career, having worked with esteemed institutions such as the University of Washington and Zymogenetics, Inc. His experiences in these organizations have greatly influenced his innovative pursuits and have facilitated the development of his groundbreaking patents.

Collaborations

Throughout his career, Keith B. Elkon has collaborated with talented individuals, including Jeffrey A. Ledbetter and Martha Susan Hayden-Ledbetter. These partnerships have undoubtedly enriched his research and led to further advancements in his work.

Conclusion

Keith B. Elkon's contributions to the field of biotechnology through his innovative patents are commendable. His ongoing research and collaborations will likely continue to inspire future advancements and improvements in treating immune-related diseases. As he progresses in his career, the impact of his work will be keenly observed within the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…